 | • レポートコード：GIR-107A12681 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、風疹診断検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。風疹診断検査の種類別市場規模（フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価）、用途別市場規模（病院、商業、医師オフィス、公衆衛生研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・風疹診断検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Beckman Coulter、Bio Rad Laboratories、Biogate Laboratories、BioMerieux SA、Cigna、Diagnostic Laboratory of Oklahoma、GlaxoSmithKline、HealthLink BC、Mayo Clinic、Ortho Clinical Diagnostics、True Health ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価 ・用途別分析2016年-2026年：病院、商業、医師オフィス、公衆衛生研究所、その他 ・風疹診断検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・風疹診断検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・風疹診断検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・風疹診断検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・風疹診断検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rubella Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rubella Diagnostic Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Rubella Diagnostic Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rubella Diagnostic Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation
Market segment by Application, can be divided into
Hospitals
Commercial
Physician Offices
Public Health Labs
Other
Market segment by players, this report covers
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Rubella Diagnostic Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Rubella Diagnostic Testing, with revenue, gross margin and global market share of Rubella Diagnostic Testing from 2019 to 2021.
Chapter 3, the Rubella Diagnostic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Rubella Diagnostic Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Rubella Diagnostic Testing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Rubella Diagnostic Testing
1.2 Classification of Rubella Diagnostic Testing by Type
1.2.1 Overview: Global Rubella Diagnostic Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rubella Diagnostic Testing Revenue Market Share by Type in 2020
1.2.3 Flow Cytometry
1.2.4 Latex Slide Agglutination Test
1.2.5 Monoclonal Antibodies
1.2.6 Immunoassays
1.2.7 Serological Testing
1.2.8 Clinical Evaluation
1.3 Global Rubella Diagnostic Testing Market by Application
1.3.1 Overview: Global Rubella Diagnostic Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Commercial
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Other
1.4 Global Rubella Diagnostic Testing Market Size & Forecast
1.5 Global Rubella Diagnostic Testing Market Size and Forecast by Region
1.5.1 Global Rubella Diagnostic Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rubella Diagnostic Testing Market Size by Region, (2016-2021)
1.5.3 North America Rubella Diagnostic Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Rubella Diagnostic Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rubella Diagnostic Testing Market Size and Prospect (2016-2026)
1.5.6 South America Rubella Diagnostic Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rubella Diagnostic Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rubella Diagnostic Testing Market Drivers
1.6.2 Rubella Diagnostic Testing Market Restraints
1.6.3 Rubella Diagnostic Testing Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Rubella Diagnostic Testing Product and Solutions
2.1.4 Abbott Laboratories Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Rubella Diagnostic Testing Product and Solutions
2.2.4 Beckman Coulter Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Bio Rad Laboratories
2.3.1 Bio Rad Laboratories Details
2.3.2 Bio Rad Laboratories Major Business
2.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Product and Solutions
2.3.4 Bio Rad Laboratories Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio Rad Laboratories Recent Developments and Future Plans
2.4 Biogate Laboratories
2.4.1 Biogate Laboratories Details
2.4.2 Biogate Laboratories Major Business
2.4.3 Biogate Laboratories Rubella Diagnostic Testing Product and Solutions
2.4.4 Biogate Laboratories Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Biogate Laboratories Recent Developments and Future Plans
2.5 BioMerieux SA
2.5.1 BioMerieux SA Details
2.5.2 BioMerieux SA Major Business
2.5.3 BioMerieux SA Rubella Diagnostic Testing Product and Solutions
2.5.4 BioMerieux SA Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 BioMerieux SA Recent Developments and Future Plans
2.6 Cigna
2.6.1 Cigna Details
2.6.2 Cigna Major Business
2.6.3 Cigna Rubella Diagnostic Testing Product and Solutions
2.6.4 Cigna Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Cigna Recent Developments and Future Plans
2.7 Diagnostic Laboratory of Oklahoma
2.7.1 Diagnostic Laboratory of Oklahoma Details
2.7.2 Diagnostic Laboratory of Oklahoma Major Business
2.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product and Solutions
2.7.4 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Diagnostic Laboratory of Oklahoma Recent Developments and Future Plans
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Rubella Diagnostic Testing Product and Solutions
2.8.4 GlaxoSmithKline Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GlaxoSmithKline Recent Developments and Future Plans
2.9 HealthLink BC
2.9.1 HealthLink BC Details
2.9.2 HealthLink BC Major Business
2.9.3 HealthLink BC Rubella Diagnostic Testing Product and Solutions
2.9.4 HealthLink BC Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 HealthLink BC Recent Developments and Future Plans
2.10 Mayo Clinic
2.10.1 Mayo Clinic Details
2.10.2 Mayo Clinic Major Business
2.10.3 Mayo Clinic Rubella Diagnostic Testing Product and Solutions
2.10.4 Mayo Clinic Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Mayo Clinic Recent Developments and Future Plans
2.11 Ortho Clinical Diagnostics
2.11.1 Ortho Clinical Diagnostics Details
2.11.2 Ortho Clinical Diagnostics Major Business
2.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Product and Solutions
2.11.4 Ortho Clinical Diagnostics Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
2.12 True Health
2.12.1 True Health Details
2.12.2 True Health Major Business
2.12.3 True Health Rubella Diagnostic Testing Product and Solutions
2.12.4 True Health Rubella Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 True Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rubella Diagnostic Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Rubella Diagnostic Testing Players Market Share
3.2.2 Top 10 Rubella Diagnostic Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Rubella Diagnostic Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rubella Diagnostic Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Rubella Diagnostic Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rubella Diagnostic Testing Revenue Market Share by Application (2016-2021)
5.2 Rubella Diagnostic Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rubella Diagnostic Testing Revenue by Type (2016-2026)
6.2 North America Rubella Diagnostic Testing Revenue by Application (2016-2026)
6.3 North America Rubella Diagnostic Testing Market Size by Country
6.3.1 North America Rubella Diagnostic Testing Revenue by Country (2016-2026)
6.3.2 United States Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rubella Diagnostic Testing Revenue by Type (2016-2026)
7.2 Europe Rubella Diagnostic Testing Revenue by Application (2016-2026)
7.3 Europe Rubella Diagnostic Testing Market Size by Country
7.3.1 Europe Rubella Diagnostic Testing Revenue by Country (2016-2026)
7.3.2 Germany Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
7.3.3 France Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rubella Diagnostic Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Rubella Diagnostic Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Region
8.3.1 Asia-Pacific Rubella Diagnostic Testing Revenue by Region (2016-2026)
8.3.2 China Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
8.3.5 India Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rubella Diagnostic Testing Revenue by Type (2016-2026)
9.2 South America Rubella Diagnostic Testing Revenue by Application (2016-2026)
9.3 South America Rubella Diagnostic Testing Market Size by Country
9.3.1 South America Rubella Diagnostic Testing Revenue by Country (2016-2026)
9.3.2 Brazil Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rubella Diagnostic Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Rubella Diagnostic Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Country
10.3.1 Middle East & Africa Rubella Diagnostic Testing Revenue by Country (2016-2026)
10.3.2 Turkey Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Rubella Diagnostic Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Rubella Diagnostic Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rubella Diagnostic Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rubella Diagnostic Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rubella Diagnostic Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rubella Diagnostic Testing Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Rubella Diagnostic Testing Product and Solutions
Table 9. Abbott Laboratories Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 11. Beckman Coulter Major Business
Table 12. Beckman Coulter Rubella Diagnostic Testing Product and Solutions
Table 13. Beckman Coulter Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio Rad Laboratories Major Business
Table 16. Bio Rad Laboratories Rubella Diagnostic Testing Product and Solutions
Table 17. Bio Rad Laboratories Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Biogate Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Biogate Laboratories Major Business
Table 20. Biogate Laboratories Rubella Diagnostic Testing Product and Solutions
Table 21. Biogate Laboratories Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. BioMerieux SA Corporate Information, Head Office, and Major Competitors
Table 23. BioMerieux SA Major Business
Table 24. BioMerieux SA Rubella Diagnostic Testing Product and Solutions
Table 25. BioMerieux SA Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Cigna Corporate Information, Head Office, and Major Competitors
Table 27. Cigna Major Business
Table 28. Cigna Rubella Diagnostic Testing Product and Solutions
Table 29. Cigna Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Diagnostic Laboratory of Oklahoma Corporate Information, Head Office, and Major Competitors
Table 31. Diagnostic Laboratory of Oklahoma Major Business
Table 32. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product and Solutions
Table 33. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 35. GlaxoSmithKline Major Business
Table 36. GlaxoSmithKline Rubella Diagnostic Testing Product and Solutions
Table 37. GlaxoSmithKline Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. HealthLink BC Corporate Information, Head Office, and Major Competitors
Table 39. HealthLink BC Major Business
Table 40. HealthLink BC Rubella Diagnostic Testing Product and Solutions
Table 41. HealthLink BC Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Mayo Clinic Corporate Information, Head Office, and Major Competitors
Table 43. Mayo Clinic Major Business
Table 44. Mayo Clinic Rubella Diagnostic Testing Product and Solutions
Table 45. Mayo Clinic Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Ortho Clinical Diagnostics Major Business
Table 48. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product and Solutions
Table 49. Ortho Clinical Diagnostics Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. True Health Corporate Information, Head Office, and Major Competitors
Table 51. True Health Major Business
Table 52. True Health Rubella Diagnostic Testing Product and Solutions
Table 53. True Health Rubella Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Rubella Diagnostic Testing Revenue (USD Million) by Players (2019-2021)
Table 55. Global Rubella Diagnostic Testing Revenue Share by Players (2019-2021)
Table 56. Breakdown of Rubella Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Rubella Diagnostic Testing Players Head Office, Products and Services Provided
Table 58. Rubella Diagnostic Testing Mergers & Acquisitions in the Past Five Years
Table 59. Rubella Diagnostic Testing New Entrants and Expansion Plans
Table 60. Global Rubella Diagnostic Testing Revenue (USD Million) by Type (2016-2021)
Table 61. Global Rubella Diagnostic Testing Revenue Share by Type (2016-2021)
Table 62. Global Rubella Diagnostic Testing Revenue Forecast by Type (2021-2026)
Table 63. Global Rubella Diagnostic Testing Revenue by Application (2016-2021)
Table 64. Global Rubella Diagnostic Testing Revenue Forecast by Application (2021-2026)
Table 65. North America Rubella Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Rubella Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Rubella Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Rubella Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Rubella Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Rubella Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Rubella Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Rubella Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Rubella Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Rubella Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Rubella Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Rubella Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Rubella Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Rubella Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Rubella Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Rubella Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Rubella Diagnostic Testing Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Rubella Diagnostic Testing Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Rubella Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Rubella Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Rubella Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Rubella Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Rubella Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Rubella Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Rubella Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Rubella Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Rubella Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Rubella Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Rubella Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Rubella Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rubella Diagnostic Testing Picture
Figure 2. Global Rubella Diagnostic Testing Revenue Market Share by Type in 2020
Figure 3. Flow Cytometry
Figure 4. Latex Slide Agglutination Test
Figure 5. Monoclonal Antibodies
Figure 6. Immunoassays
Figure 7. Serological Testing
Figure 8. Clinical Evaluation
Figure 9. Rubella Diagnostic Testing Revenue Market Share by Application in 2020
Figure 10. Hospitals Picture
Figure 11. Commercial Picture
Figure 12. Physician Offices Picture
Figure 13. Public Health Labs Picture
Figure 14. Other Picture
Figure 15. Global Rubella Diagnostic Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Rubella Diagnostic Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Rubella Diagnostic Testing Revenue Market Share by Region (2016-2026)
Figure 18. Global Rubella Diagnostic Testing Revenue Market Share by Region in 2020
Figure 19. North America Rubella Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Rubella Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Rubella Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Rubella Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa Rubella Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Rubella Diagnostic Testing Market Drivers
Figure 25. Rubella Diagnostic Testing Market Restraints
Figure 26. Rubella Diagnostic Testing Market Trends
Figure 27. Abbott Laboratories Recent Developments and Future Plans
Figure 28. Beckman Coulter Recent Developments and Future Plans
Figure 29. Bio Rad Laboratories Recent Developments and Future Plans
Figure 30. Biogate Laboratories Recent Developments and Future Plans
Figure 31. BioMerieux SA Recent Developments and Future Plans
Figure 32. Cigna Recent Developments and Future Plans
Figure 33. Diagnostic Laboratory of Oklahoma Recent Developments and Future Plans
Figure 34. GlaxoSmithKline Recent Developments and Future Plans
Figure 35. HealthLink BC Recent Developments and Future Plans
Figure 36. Mayo Clinic Recent Developments and Future Plans
Figure 37. Ortho Clinical Diagnostics Recent Developments and Future Plans
Figure 38. True Health Recent Developments and Future Plans
Figure 39. Global Rubella Diagnostic Testing Revenue Share by Players in 2020
Figure 40. Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Rubella Diagnostic Testing Revenue Market Share in 2020
Figure 42. Global Top 10 Players Rubella Diagnostic Testing Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Rubella Diagnostic Testing Revenue Share by Type in 2020
Figure 45. Global Rubella Diagnostic Testing Market Share Forecast by Type (2021-2026)
Figure 46. Global Rubella Diagnostic Testing Revenue Share by Application in 2020
Figure 47. Global Rubella Diagnostic Testing Market Share Forecast by Application (2021-2026)
Figure 48. North America Rubella Diagnostic Testing Sales Market Share by Type (2016-2026)
Figure 49. North America Rubella Diagnostic Testing Sales Market Share by Application (2016-2026)
Figure 50. North America Rubella Diagnostic Testing Revenue Market Share by Country (2016-2026)
Figure 51. United States Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Rubella Diagnostic Testing Sales Market Share by Type (2016-2026)
Figure 55. Europe Rubella Diagnostic Testing Sales Market Share by Application (2016-2026)
Figure 56. Europe Rubella Diagnostic Testing Revenue Market Share by Country (2016-2026)
Figure 57. Germany Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Rubella Diagnostic Testing Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Rubella Diagnostic Testing Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Rubella Diagnostic Testing Revenue Market Share by Region (2016-2026)
Figure 65. China Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Rubella Diagnostic Testing Sales Market Share by Type (2016-2026)
Figure 72. South America Rubella Diagnostic Testing Sales Market Share by Application (2016-2026)
Figure 73. South America Rubella Diagnostic Testing Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Rubella Diagnostic Testing Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Rubella Diagnostic Testing Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Rubella Diagnostic Testing Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Rubella Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のバイオマーカー検査市場 2021：企業別、地域別、種類・用途別 The Biomarker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …- 世界のマグネシウム試験試薬市場 2021：企業別、地域別、種類・用途別 The Magnesium Testing Reagent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界の子宮頸がん診断市場 2021：企業別、地域別、種類・用途別 The Cervical Cancer Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の一酸化窒素喘息検査市場 2021：企業別、地域別、種類・用途別 The Nitric Oxide Asthma Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界のゾリンジャー-エリソン症候群検査市場 2021：企業別、地域別、種類・用途別 The Zollinger - Ellison Syndrome Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …